Building India's Precision Medicine Ecosystem, From Sequencing to Local Manufacturing
Precision medicine is redefining healthcare by enabling faster, more accurate and personalised treatment strategies. Harkaran Dhingra, CEO, DSS Takara Bio India, shares with Pharma Industrial India, insights on India’s precision medicine landscape, the expanding use of Next Generation Sequencing (NGS), gene editing, RNA therapeutics, single-cell technologies, local manufacturing under the ‘Make in India’ initiative, and the collaborations accelerating research and clinical innovation.
Precision Medicine | 08/09/2026
Pharma 2025: The Year of Convergence, Accountability, and Intelligent Acceleration
This year, pharma industry finds itself not in a state of flux, but of fusion—where technology, data, and human purpose converge to redefine the very fabric of healthcare innovation. No longer confined to incremental change, pharma is embracing a paradigm of intelligent acceleration—balancing speed with accountability, and progress with purpose.
Precision Medicine | 11/12/2025
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy